The Intestin-Euvernil brand, founded in 1953 (Germany), from 496 sister brands and 17477 competing brands. Intestin-Euvernil is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York Intestin-Euvernil belongs to the Drug Manufacturers business sector.

Intestin-Euvernil is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Share price

International deposit : 1953 Business sector Drug Manufacturers

Share price and profitability of the share BRISTOL-MYERS SQUIBB COMPANY (Intestin-Euvernil)

Buy BRISTOL-MYERS SQUIBB COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 44.21

Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY (Intestin-Euvernil) over 5 years* USD 40.83

Stock market history BRISTOL-MYERS SQUIBB COMPANY (Intestin-Euvernil)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
BRISTOL-MYERS SQUIBB COMPANY

FORBIUS
FORBIUS
Kosan Biosciences
Kosan Biosciences
Galecto Biotech
Galecto Biotech
Flexus Biosciences
Flexus Biosciences
Medarex
Medarex
ZymoGenetics
ZymoGenetics
See more brands of BRISTOL-MYERS SQUIBB COMPANY

Rival brands
Intestin-Euvernil

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS